Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$269.97
▼ $3.17 (−1.16%) today
Markets open · 2:36pm ET

JNJ Coverage

Page 87
3:45am ET
Media

Media Digest 12/29/2008 Reuters, WSJ, FT, Bloomberg

According to Reuters, Kuwait canceled a $17 billion joint venture with Dow Chemical (DOW). Reuters reports that Credit Suisse (CS) clients may have lost $926 million on the Madoff scam. Reuters reports…

Douglas A. McIntyre
8:21am ET
Health and Healthcare

J&J: Now Master Over Mentor (MNT, JNJ)

If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities.  Mentor Corp. (NYSE: MNT) has just secured a major premium buyout this…

JNJ
Douglas A. McIntyre
6:45am ET
Health and Healthcare

Omrix Gets Acquired By J&J (OMRI, JNJ)

It looks as though not quite all the mergers are dead on the medical tech and biotechnology front.  Johnson & Johnson (NYSE: JNJ) announced that it is acquiring Omrix Biopharmaceuticals, Inc. (NASDAQ:…

JNJ
Douglas A. McIntyre